Gsk (GLAXF) FCF Payout Ratio (2009 - 2026)
Gsk (GLAXF) recorded quarterly FCF Payout Ratio of 0.41 in Q1 2026, down 115.64% quarter-over-quarter from 0.19 in Q4 2025, and down 0.92% on a YoY basis from 0.41 in Q1 2025.
Gsk (GLAXF) FCF Payout Ratio (2009 - 2026) Analysis & Trends
Gsk's FCF Payout Ratio history runs 18 years deep, the most recent figure standing at 0.41 for Q1 2026.
- In Q1 2026, FCF Payout Ratio fell 0.92% year-over-year to 0.41; the TTM figure through Mar 2026 stood at 0.3 (down 76.29% YoY), while the FY2025 annual figure was 0.4, down 15.41% from the prior year.
- FCF Payout Ratio was 0.41 for Q1 2026 at Gsk, down from 0.19 in the prior quarter.
- In the past five years, FCF Payout Ratio ranged from a high of 0.02 in Q4 2023 to a low of 16.73 in Q4 2022.
- Historically, FCF Payout Ratio has averaged 1.4 across 5 years, with a median of 0.39 in 2024.
- The sharpest annual moves came in 2022 and 2023: FCF Payout Ratio tumbled 17911.56% in 2022, then jumped 99.86% in 2023.
- A 5-year view of FCF Payout Ratio shows it stood at 16.73 in 2022, then surged by 99.86% to 0.02 in 2023, then tumbled by 59.21% to 0.04 in 2024, then sank by 392.31% to 0.19 in 2025, then plunged by 115.64% to 0.41 in 2026.
- The last three FCF Payout Ratio figures came in at 0.41 (Q1 2026), 0.19 (Q4 2025), and 0.32 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | -0.41 |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | 0.51 |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | 2.14 |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | 0.87 |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | 0.72 |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | 0.92 |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 0.43 |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | 1.12 |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | 1.69 |
| 10 | Gsk | - | - | 7.76 Bn | -0.41 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.41 |
| Dec 31, 2025 | -0.19 |
| Sep 30, 2025 | -0.32 |
| Jun 30, 2025 | -0.48 |
| Mar 31, 2025 | -0.41 |
| Dec 31, 2024 | -0.04 |
| Sep 30, 2024 | -0.26 |
| Jun 30, 2024 | -0.37 |
| Mar 31, 2024 | -0.41 |
| Dec 31, 2023 | -0.02 |
| Sep 30, 2023 | -0.19 |
| Jun 30, 2023 | -0.46 |
| Mar 31, 2023 | -1.07 |
| Dec 31, 2022 | -16.73 |
| Sep 30, 2022 | -0.77 |
| Mar 31, 2022 | -0.35 |
| Dec 31, 2021 | -0.09 |
| Sep 30, 2021 | -0.04 |
| Jun 30, 2021 | -0.05 |
| Mar 31, 2021 | -1.78 |